Schonfeld Strategic Advisors LLC - Significant Ownership

Signature - Title
/s/ Hung Luc - Hung Luc, Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Schonfeld Strategic Advisors LLC.

Significant Ownership of Schonfeld Strategic Advisors LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TERN Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.93% $9.9M -$2.14M 4.31M -17.8% Schonfeld Strategic Advisors LLC Mar 31, 2025
MRSN Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.55% $1.76M -$601K 5.67M -25.5% Schonfeld Strategic Advisors LLC Jun 30, 2025
SKYE Skye Bioscience, Inc. Common Stock, par value $0.001 per share 3.6% $3.86M -$1.74M 1.12M -31% Schonfeld Strategic Advisors LLC Jun 30, 2025
APLT Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.3% $1.5M -$1.31M 4.68M -46.7% Schonfeld Strategic Advisors LLC Mar 31, 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 2.82% $763K 1.31M Schonfeld Strategic Advisors LLC Dec 31, 2024
FATE Fate Therapeutics, Inc. Common Stock, par value $0.001 per share 0.82% $1.05M -$7.68M 938K -88% Schonfeld Strategic Advisors LLC Jun 30, 2025

Schedules 13D/G Reported by Schonfeld Strategic Advisors LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.